Showing results (831-840 of 1,251) with videos related to
Sort By:
Pageof 126
Cancer Treatment and Research Communications|March 3, 2026
Conversion treatment with hepatic arterial infusion of oxaliplatin, leucovorin and fluorouracil plus intravenous bevacizumab or cetuximab for initially unresectable colorectal liver metastasis: A prospective studyWei Liao, Qi Cheng, Lin Chen, et al.Cancer Treatment and Research Communications|March 10, 2026
Circular RNAs as emerging regulators of mitochondrial function and diseaseMehrzad Esmaeili Niasan, Soudeh Ghafouri-FardCancer Treatment and Research Communications|February 8, 2024
Surgical margin and local recurrence of ductal carcinoma in situMichael Co, Maggie Wai Yin Fung, Ava KwongCancer Treatment and Research Communications|February 17, 2024
Clinical and pathological differences between early- and late-onset colorectal cancer and determinants of one-year all-cause mortality among advanced-stage patients: a retrospective cohort study in Medellín, ColombiaÁlvaro Esteban Ruiz-Grajales, Manuela María Orozco-Puerta, Senshuang Zheng, et al.Cancer Treatment and Research Communications|February 17, 2024
Liposomes for the treatment of prostate cancer therapy: A reviewChinmaya Keshari Sahoo, Nalini Kanta Sahoo, Madhusmita Sahu, et al.Cancer Treatment and Research Communications|July 26, 2023
High tumor mutation burden (TMB) in microsatellite stable (MSS) colorectal cancers: Diverse molecular associations point to variable pathophysiologyIoannis A VoutsadakisCancer Treatment and Research Communications|March 20, 2026
HDAC4 overexpression predicts aggressive phenotypes and poor outcomes in urothelial carcinomaHau-Chern Jan, Ying-Chieh Su, Steven Kuan-Hua Huang, et al.Cancer Treatment and Research Communications|March 20, 2026
The Mesopancreas remains at risk in primary resectable pancreatic cancer patients: time to reappraise resectability criteria?Stephan O David, Andrea Alexander, Farid Ziayee, et al.Cancer Treatment and Research Communications|March 19, 2026
Association between biochemical and histopathological parameters in the clinical assessment of prostate tumors in a resource-limited setting in northern CameroonRichard Tagne Simo, Larissa Pélagie Nodjia, Armel Hervé Nwabo Kamdje, et al.Cancer Treatment and Research Communications|March 18, 2026
Assessing the correlation between CD15 expression and gleason score and grade groups in prostate adenocarcinoma: A cross-sectional studyMahdi Karamvand, Mohammad Mahdi Mehrabi, Mohammadreza Jalali NadoushanPageof 126